Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Real-Time Price · USD

17.63

+0.24 (1.38%)

At close: Aug 14, 2026, 4:00 PM EDT

17.58

-0.05 (-0.28%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Revenue Breakdown 2

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
GI Revenue (Post-FY2024 Reporting)	1.45T	1.41T	1.36T
Rare Diseases Revenue (Post-FY2024 Reporting)	772.30B	762.70B	752.82B
PDT Revenue (Post-FY2024 Reporting)	1.08T	1.06T	1.03T
Oncology Revenue (Post-FY2024 Reporting)	606.90B	580.13B	560.43B
Vaccines Revenue	62.10B	59.61B	55.41B
Neuroscience Revenue (Post-FY2024 Reporting)	419.30B	414.34B	565.82B
Other Product Revenue (Post-FY2024 Reporting)	223.50B	223.96B	257.39B
Revenue (Total)	4.62T	4.51T	4.58T

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Japan Revenue	429.00B	433.11B	418.46B
United States Revenue	2.19T	2.16T	2.38T
Latin America Revenue	270.70B	254.13B	235.85B
China Revenue	204.20B	195.14B	191.74B
Asia (ex-Japan & China) Revenue	102.30B	98.67B	99.39B
Asia (ex-Japan) Revenue	306.50B	293.81B	291.13B
Russia / CIS Revenue	86.20B	79.72B	72.36B
Europe and Canada Revenue	-	1.15T	1.06T
Other Geographic Revenue (Pre-FY2027 Reporting)	-	133.89B	128.85B
Revenue (Other)	1.34T	-20.00M	1.00M
Revenue (Total)	4.62T	4.51T	4.58T